Global Spinal Muscular Atrophy Market Growth Impelled by Increasing Prevalence of Spinal Muscular Atrophy

April 12, 2023 | Healthcare

According to the latest report by IMARC Group, titled "Spinal Muscular Atrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033," the global spinal muscular atrophy market size is witnessing steady growth. Spinal muscular atrophy is a genetic disorder that affects the nerves responsible for controlling voluntary muscles. It is a progressive condition that can cause muscle weakness and atrophy, or shrinkage, leading to difficulties with movement, breathing, and swallowing. SMA is caused by a defect in the survival motor neuron 1 (SMN1) gene, resulting in an SMN protein deficiency. This protein is essential for the survival and function of motor neurons responsible for sending signals from the brain to the muscles. Some of the treatment options for SMA include medications, such as nusinersen and onasemnogene abeparvovec, that aim to increase the production of the SMN protein. Physical therapy and assistive devices, such as braces and wheelchairs, may also manage symptoms and improve quality of life. Gene therapy, which involves replacing or repairing the defective SMN1 gene, is also being investigated as a potential treatment option for SMA. 

Global Spinal Muscular Atrophy Market Trends:

The global market is majorly driven by the increasing prevalence of spinal muscular atrophy. In line with this, the development of innovative therapies for its treatment is significantly contributing to the market growth. Furthermore, the availability of advanced healthcare infrastructure is positively influencing the market. Apart from this, the rising awareness and access to innovative therapies are catalyzing the market. Moreover, the key companies are focusing on developing innovative therapies for SMA and investing in research and development to improve treatment options. Besides, the rapid advancements in gene therapy and drug therapy are expected to create a positive outlook for the market. Additionally, the growing approval of new disease-modifying therapies is projected to provide a boost to the market. Some of the other factors driving the market include the increasing product launches, rising research and development initiatives, and growing access to the reimbursement of expensive drugs globally. 

Market Summary:

  • On the basis of the marketed products, the market has been categorized into Evrysdi (Risdiplam) - PTC Therapeutics/Roche, Spinraza (Nusinersen) - Biogen/Ionis Pharmaceuticals, and Zolgensma (Onasemnogene abeparvovec) - Novartis Gene Therapies/Nationwide Children's Hospital.
  • Based on the pipeline drugs, the market has been classified into RG 6237 - Hoffmann-La Roche, SRK015 - Scholar Rock and ACTX 401 - Alcyone Therapeutics.
  • On the basis of the region, the market has been divided into the United States, Germany, France, the United Kingdom, Italy, Spain, and Japan.
  • The competitive landscape of the market has been studied in the report with detailed profiles of the key players operating in the market.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Spinal Muscular Atrophy Market Growth Impelled by Increasing Prevalence of Spinal Muscular Atrophy
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More